Guard Therapeutics (publ) today announced that the last patient in its ongoing Phase 2b clinical trial, POINTER, has successfully completed the final scheduled follow-up visit 90 days after surgery (l ...

Our research team is launching a new initiative to collect and preserve first-person accounts from scientists, engineers, and ...

Olu of Warri, Ogiame Atuwatse III, has intervened to rescue Itsekiri students of Novena University, Ogume, Ndokwa West, Delta State, who graduated under the Presidential Amnesty Programme, PAP, but ...